MRT(MRT)
MRT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $70M | $116M |
| Low | $70M | $98M |
| High | $70M | $134M |
| EBITDA Avg | $-42M | $-69M |
| Low | $-42M | $-80M |
| High | $-42M | $-58M |
| EBIT Avg | $-55M | $-91M |
| Low | $-55M | $-105M |
| High | $-55M | $-76M |
| Net Income Avg | $-21M | $-5M |
| Low | $-23M | $-6M |
| High | $-17M | $-4M |
| EPS Avg | $-0.26 | $-0.07 |
| Low | $-0.29 | $-0.07 |
| High | $-0.22 | $-0.06 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $19M | $19M | $28M | $42M | $47M | $67M |
| Low | $19M | $19M | $28M | $42M | $47M | $67M |
| High | $19M | $19M | $28M | $42M | $47M | $67M |
| EBITDA Avg | $-11M | $-11M | $-17M | $-25M | $-28M | $-40M |
| Low | $-11M | $-11M | $-17M | $-25M | $-28M | $-40M |
| High | $-11M | $-11M | $-17M | $-25M | $-28M | $-40M |
| EBIT Avg | $-14M | $-15M | $-22M | $-33M | $-36M | $-53M |
| Low | $-14M | $-15M | $-22M | $-33M | $-36M | $-53M |
| High | $-14M | $-15M | $-22M | $-33M | $-36M | $-53M |
| Net Income Avg | $-5M | $-5M | $-14M | $-6M | $-7M | $3M |
| Low | $-5M | $-5M | $-14M | $-6M | $-7M | $3M |
| High | $-5M | $-5M | $-14M | $-6M | $-7M | $3M |
| EPS Avg | $-0.06 | $-0.06 | $-0.17 | $-0.07 | $-0.09 | $0.04 |
| Low | $-0.06 | $-0.06 | $-0.17 | $-0.07 | $-0.09 | $0.04 |
| High | $-0.06 | $-0.06 | $-0.17 | $-0.07 | $-0.09 | $0.04 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |